Flusilazole

Flusilazole

SCHEMBL3007591

C[Si](Cn1cncn1)(c1ccc(F)cc1)c1ccc(F)cc1.Fc1ccc(C([SiH2]Cn2cncn2)c2ccc(F)cc2)cc1

nearest known ligand 0.48

Full drug profile on Sugi Atlas →

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 11/20 0.48
KMT2A Q03164 1/20 0.36
CYP3A4 P08684 3/20 0.34
CYP2C9 P11712 3/20 0.34
CYP2C19 P33261 3/20 0.34
LMNA P02545 2/20 0.34
HSP90AA1 P07900 1/20 0.34
CYP11B1 P15538 1/20 0.34
CYP11B2 P19099 1/20 0.34
ADRA1A P35348 1/20 0.34
CYP51A1 Q16850 1/20 0.34
CYP1A2 P05177 2/20 0.32
CYP2D6 P10635 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
FAAH O00519 1/20 0.32
MGLL Q99685 1/20 0.32
MAPK1 P28482 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL54018 0.88 CYP19A1 (0.59) CYP19A1KMT2ACYP3A4CYP2C9CYP2C19
Flusilazole SCHEMBL7049517 0.87 CYP19A1 (0.49) CYP19A1KMT2ACYP3A4CYP2C9CYP2C19
Flusilazole SCHEMBL21313 0.87 CYP19A1 (0.49) CYP19A1KMT2ACYP3A4CYP2C9CYP2C19
Flusilazole SCHEMBL8677611 0.87 CYP19A1 (0.49) CYP19A1KMT2ACYP3A4CYP2C9CYP2C19
SCHEMBL10940035 0.81 CYP19A1 (0.48) CYP19A1KMT2ACYP3A4CYP2C9CYP2C19
SCHEMBL17018813 0.81 CYP19A1 (0.44) CYP19A1KMT2ACYP3A4CYP2C9CYP2C19
SCHEMBL11032944 0.81 CYP19A1 (0.48) CYP19A1KMT2ACYP3A4CYP2C9CYP2C19
SCHEMBL9676982 0.78 CYP19A1 (0.49) CYP19A1KMT2ACYP3A4CYP2C9CYP2C19
SCHEMBL9676996 0.78 CYP19A1 (0.51) CYP19A1KMT2ACYP3A4CYP2C9CYP2C19
SCHEMBL9677119 0.78 CYP19A1 (0.51) CYP19A1KMT2ACYP3A4CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100305161-A1 COMBINATIONS OF FUNGICIDAL AZOLES AND PYRION COMPOUNDS BOSSELAERS JAN PETER HENDRIK 2010-12-02 US disclosed
EP-2224814-A2 COMBINATIONS OF FUNGICIDAL AZOLES AND PYRION COMPOUNDS Janssen Pharmaceutica, N.V. (BE) 2010-09-08 EP disclosed
US-7662748-B2 Such as azaconazole, bromuconazole, and N,N',N'-tris(2-hydroxyethyl)-N-cocoalkyl-1,3-diamino-propane; kits; for protection of crops, plants, fruits, seeds, wood products, thatch, biodegradable material and textiles JANSSEN PHARMACEUTICA, N.V. (BE) 2010-02-16 US disclosed
WO-2009068606-A2 COMBINATIONS OF FUNGICIDAL TRIAZOLES AND PYRION COMPOUNDS JANSSEN PHARMACEUTICA NV (BE) 2009-06-04 WO disclosed
US-20050080089-A1 Formulations comprising triazoles and alkoxylated amines AKZO NOBEL CHEMICALS BV (NL) 2005-04-14 US disclosed
EP-1473996-A1 FORMULATIONS COMPRISING TRIAZOLES AND ALKOXYLATED AMINES JANSSEN PHARMACEUTICA N.V. (BE) 2004-11-10 EP disclosed
WO-2003065807-A1 FORMULATIONS COMPRISING TRIAZOLES AND ALKOXYLATED AMINES JANSSEN PHARMACEUTICA N.V. (BE) 2003-08-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050080089-A1 Formulations comprising triazoles and alkoxylated amines ALKBH3, TYR, NAT1 CYP19A1 1192/4885KMT2A 1163/4885CYP3A4 100/4885
US-20100305161-A1 COMBINATIONS OF FUNGICIDAL AZOLES AND PYRION COMPOUNDS PPOX, PNPO, CYP3A43 CYP19A1 734/4885KMT2A 4343/4885CYP3A4 7/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.